当前位置:网站首页>   郑玉玲全国名老中医药专家传承工作室  > 弟子业绩
弟子业绩

Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in the Treatment of Patients with Advanced Primary Hepatocellular Carcinoma A Retrospective, Real-World Study in China

发布日期:2022-10-17   阅读量:496